AgomAb Therapeutics NV
Disclosed SEC business address
POSTHOFLEI 1/6, ANTWERPEN, 2600
AgomAb Therapeutics NV (ticker AGMB, CIK 0002020932) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-10-18T03:18:36.607662+00:00
- SEC EDGAR · issuer filing index
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.